Latest news

News stories

This area contains news from the University since October 2020. For stories from 2010 to October 2020, use the 'News archive' above or search at the top of the page.
Image of motor neurones

Landmark MIROCALS clinical trial provides new insight into treatment of MND

Results of the landmark MIROCALS clinical trial, involving researchers from the ±¬ÁϹ«Éç, have revealed new insights into the treatment of motor neuron disease (MND).
MRI scanner

Cutting-edge MRI could revolutionise diagnosis of common heart problem aortic stenosis

Scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. 
Ernest Wright workshop

University helps historic Sheffield scissor maker sharpen its edge

A historic Sheffield scissor maker is gaining new insights into the traditional craftsmanship that it has used to lovingly handcraft scissors for over a century through a collaboration with the ±¬ÁϹ«Éç.
DNA strand

FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP)

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47).
Terezia is leaning against a wooden balcony rail overlooking the work area of a library

Inspirational women celebrated in University exhibition

Inspirational women who have blazed a trail for colleagues and students are being celebrated by the ±¬ÁϹ«Éç in a portrait exhibition.
Students stood outside Firth Court

New data values international students’ benefit to Sheffield economy at £770 million

International students provide a £770 million economic benefit to the city of Sheffield, according to new figures released today (Thursday 20 June).
People walking on the concourse in the heart of the ±¬ÁϹ«Éç's campus, near its Students' Union building

An update on the ±¬ÁϹ«Éç’s sanctuary work

±¬ÁϹ«Éç is continuing to support people displaced by war or persecution through a range of scholarships, placements and educational initiatives.

Pam Shaw in front of SITraN

Comment: A devastating setback for MND research: Why NICE needs to reconsider its approach to tofersen

Professor Dame Pamela Shaw, Director of the Sheffield Institute for Translational Neuroscience, discusses NICE's refusal to classify the MND drug tofersen, as a treatment for a highly specialised condition, rather than just a standard drug.
Dementia patient

New clue in understanding increased Alzheimer’s risk

Scientists have discovered a new piece of the puzzle in understanding why some people are more susceptible to Alzheimer’s disease.